Thomas Dilenge
PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY at BIOTECHNOLOGY INNOVATION ORGANIZATION · DC
$1.4M
Peak Total Compensation
5
Years Tracked
19x
vs. Median Household
Thomas Dilenge has appeared in compensation disclosures over 5 years of available data (2016–2021). Total compensation changed from $668,830 to $1,395,072 - a 108.6% increase.
Peak total compensation of $1,395,072 equals 19x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2021 | BIOTECHNOLOGY INNOVATION ORGANIZATION | PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY | $1,355,976 | $39,096 | $1,395,072 |
| 2019 | BIOTECHNOLOGY INNOVATION ORGANIZATION | PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY | $790,497 | $69,000 | $859,497 |
| 2018 | BIOTECHNOLOGY INNOVATION ORGANIZATION | PRESIDENT, ADVOCACY/LAW/PUBLIC POLIC | $707,288 | $72,513 | $779,801 |
| 2017 | BIOTECHNOLOGY INNOVATION ORGANIZATION | PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY DIV | $701,370 | $71,486 | $772,856 |
| 2016 | BIOTECHNOLOGY INNOVATION ORGANIZATION | PRESIDENT, ADVOCACY, LAW & PUBLIC POLICY DIV | $604,209 | $64,621 | $668,830 |
Peers at BIOTECHNOLOGY INNOVATION ORGANIZATION
| Name | Title | Peak Comp. |
|---|---|---|
| James Greenwood | PRESIDENT AND CEO (UNTIL 5/31/20) | $7.6M |
| James C Greenwood | PRESIDENT & CHIEF EXECUTIVE OFFICER | $5.3M |
| John F Crowley | PRESIDENT AND CEO | $3.1M |
| Michelle McMurry-Heath | FORMER PRESIDENT AND CEO | $2.6M |
| Rachel K King | INTERIM PRESIDENT AND CEO | $1.7M |
| Elizabeth Cartier Esham | CHIEF SCIENCE OFFICER | $1.0M |
| Brent Erickson | EVP, INDUSTRIAL & ENVIRONMENT | $985K |
| Stephen Jasko | CHIEF BUSINESS AND FINANCIAL OFFICER | $895K |
| Richard Masters | CHIEF PUBLIC AFFAIRS & MARKETING OFF | $847K |
| Tom Dilenge | PRESIDENT, ADVOCACY/LAW/PUBLIC POLICY DIV | $840K |
Email Alerts
Get notified about Thomas Dilenge
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →